ABC | Volume 111, Nº3, Setembro 2018

Diretrizes Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda Arq Bras Cardiol. 2018; 111(3):436-539 719. De Backer D, Biston P, Devriendt J, Madl C, ChochradD, Aldecoa C, et al; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779-89. 720. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115-23. 721. Stretch R, Sauer CM, Yuh DD, Bonde P. National trends in the utilization of short-termmechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol. 2014;64(14):1407-15. 722. Borisenko O, Wylie G, Payne J, Bjessmo S, Smith J, Firmin R, et al. The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK. Interact Cardiovasc Thorac Surg. 2014;19(1):41-8. 723. Rihal CS, Naidu SS, Givertz MM, Szeto WY, Burke JA, Kapur NK, et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol. 2015;65(19):e7-e26. 724. Gilotra NA, Stevens GR. Temporary mechanical circulatory support: a review of the options, indications, and outcomes. Clin Med Insights Cardiol. 2014;8(Suppl 1):75-85. 725. Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council onCardiovascular Surgery and Anesthesia. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126(22):2648-67. 726. Haj-Yahia S, Birks EJ, Amrani M, Petrou M, Bahrami T, Dreyfus G, et al. Bridging patients after salvage frombridge to decision directly to transplant bymeans of prolonged support with the CentriMag short-termcentrifugal pump. J Thorac Cardiovasc Surg. 2009;138(1):227-30. 727. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141(4):932-9. 728. Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017;36(10):1080-6. 729. Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26(2):217-29. 730. MehraMR, Canter CE, HannanMM, SemigranMJ, Uber PA, BaranDA, et al; International Society for Heart Lung Transplantation (ISHLT) Infectious Diseases Council; International Society for Heart Lung Transplantation (ISHLT) Pediatric Transplantation Council; International Society for Heart Lung Transplantation (ISHLT) Heart Failure and Transplantation Council. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant. 2016;35(1):1-23. 731. Bacal F, Neto JD, Fiorelli AI, Mejia J, Marcondes-Braga FG, Mangini S, et al; Sociedade Brasileira de Cardiologia. [II BrazilianGuidelines for Cardiac Transplantation]. Arq Bras Cardiol. 2010;94(1 Suppl):e16-76. 732. Stevenson LW. Crisis awaiting heart transplantation: sinking the lifeboat. JAMA Intern Med. 2015;175(8):1406-9. 733. Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, Gonzalez- Vilchez F, Villa-Arranz A, Delgado-Jimenez J, et al. Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry. Circ Heart Fail. 2013;6(4):763-72. 734. Kilic A, Allen JG, Weiss ES. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data. J Heart Lung Transplant. 2013;32(5):492-8. 735. Platz E, Jhund PS, Campbell RT, McMurray JJ. Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review. Eur J Heart Fail. 2015;17(9):906-16. 736. Vital FM, Ladeira MT, Atallah AN. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev. 2013 May 31(5):CD005351. 737. Metkus TS, Albaeni A, Chandra-Strobos N, Eid SM. Incidence and prognostic impact of respiratory support in patients with ST-Segment elevation myocardial infarction. Am J Cardiol. 2017;119(2):171-7. 738. IakobishviliZ,CohenE,GartyM,BeharS,ShotanA,SandachA,etal;Heart Failure Survey in Isarel (HFSIS) Investigators. Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care. 2011;13(2):76-80. 739. Schultheiss HP, Kühl U, Cooper LT. The management of myocarditis. Eur Heart J. 2011;32(21):2616-25. 740. Dias JC, Ramos AN, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. 2 nd Brazilian Consensus on Chagas Disease, 2015. Rev Soc Bras Med Trop. 2016;49(Suppl 1):3-60. 741. World Health Organization. (WHO). Chagas disease (American trypanosomiasis). Geneva; 2015. 742. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015;90(6):33-43. 743. Almeida EA, Lima JN, Lages-Silva E, Guariento ME, Aoki FH, Torres- Morales AE, et al. Chagas' disease andHIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg. 2010;104(7):447-52. 744. Brasil. Ministério da Saúde. Protocolo clínico e diretrizes terapêuticas para manejo da infecção pelo HIV em adultos. Brasília; 2017. 745. Brasil. Ministério da Saúde. Doença de Chagas aguda no Brasil: série histórica de 2000 a 2013. Bol Epidemiol. 2015;46(21):1-9. 746. Brasil. Ministério da Saúde. Guia de Vigilância em Saúde. Brasília; 2014. 747. Brasil. Ministério da Saúde. Recomendações sobre o diagnóstico parasitológico, sorológico e molecular para confirmação da doença de Chagas aguda e crônica. Rev Patol Trop. 2013;42(4):475-8. 748. Parada H, Carrasco HA, Añez N, Fuenmayor C, Inglessis I. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol. 1997;60(1):49-54. 749. Pinto AY, Valente SA, Valente VaC, Ferreira Junior AG, Coura JR. [Acute phase of Chagas disease in the BrazilianAmazon region: study of 233 cases fromPará, Amapá andMaranhão observed between 1988 and 2005]. Rev Soc Bras Med Trop. 2008;41(6):602-14. 750. RassiAR.Faseaguda. In:BrenerAZ,Barral-NettoM. (editor).Trypanosoma cruzi e Doença de Chagas. 2ª. ed. Rio de Janeiro: Guanabara Koogan; 2000. p. 231-45. 751. Pinto AY, Valente SA, Valente Vda C. Emerging acute Chagas disease in Amazonian Brazil: case reports with serious cardiac involvement. Braz J Infect Dis. 2004;8(6):454-60. 752. Ferreira HO, Miziara JL. Aspectos clínicos da cardiopatia chagásica aguda. In: Cançado JR, Chuster M. (editors). Cardiopatia chagásica. Belo Horizonte: Imprensa Oficial; 1985. 538